Surgical Staging for Endometrial Cancer
By James W. Orr, Jr, MD, Phillip Y. Roland, MD, Pamela J. Orr, RN, OCN, and Dara D. Leichter, RN, OCN
Treatment and Management of Cancer in the Frail Elderly
By Zeba S. Geloo, MD, and William B. Ershler, MD
Palliative Care Options for Advanced Prostate Cancer
By Amir V. Kaisary, MA, ChM, FRCS, and Ross Knight, MRCS
Letter From the Editors
Right Tool, Right Time, Right Reason
By J. Lyle Bootman, PhD, and Daniel D. Von Hoff, MD, FACP
Use of Colony-Stimulating Factors in the Elderly Cancer Patient
By Gary H. Lyman, MD, MPH, FRCP (Edin), Lodovico Balducci, MD, and Yemi Agboola, MS
Cancer Mortality in the Elderly, 1960–1998: A Worldwide Approach
By Carlo La Vecchia, MD, Franca Lucchini, BSc, Eva Negri,ScD, and Fabio Levi, MD
Metastasis of an Esophageal Carcinoma to the Soft Tissue in the Elbow
By Arun Kumar, MD, Rajeev Kulkarni, MD, Emmanuel C. Besa, MD, and Carolyn E. Grotkowski, MD
Assessing the Older Cancer Patient
By Martine Extermann, MD, PhD
Pharmacy Practice
The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer:
What Should Patients Be Told?
By Judith A. Smith, PharmD, BCOP
Pharmacology of Antineoplastic Agents in Older Cancer Patients
By J. Andrew Skirvin, PharmD, Sunitha Vemulapalli, MD, and Stuart M. Lichtman, MD
The Case for Geriatric Oncology
By Lodovico Balducci, MD
A Standing Ovation for a Change in How We Treat Patients With Cancer —Forever
By Daniel D. Von Hoff, MD, FACP, and J. Lyle Bootman PhD
Managing Deep Vein Thrombosis Risk in Oncology Patients Office and Outpatient Settings
MODERATOR: Brian A. Meltzer, MD, MBA
DISCUSSANTS: Leo R. Zacharski, MS, MD, and Steven R. Deitcher, MD
Chemotherapy for Epithelial Ovarian Cancer
By Maurie Markman, MD
Diagnosis and Staging of Gynecological Malignancies
By Brigitte E. Miller, MD
The Role of Irradiation in Endometrial Cancer
By Perry W. Grigsby, MD
Surgical Management of Epithelial Ovarian Cancer
By George Coukos, MD, PhD, and Stephen C. Rubin, MD
Surveying the Field of Gynecologic Oncology
By William J. Hoskins, MD
Addressing the Quality Chasm for a New Health System in the 21st Century
By J. Lyle Bootman, PhD, and Daniel D. Von Hoff, MD
Palliative Chemotherapy for Advanced Colorectal Cancer
By Peter Simmonds, FRACP, and Tim Iveson, MD
Our Current Understanding of Genetic Alterations in Colorectal Cancer, and Implications for Clinical Use
By Manel Esteller, MD, PhD, and Montserrat Sanchez-Cespedes, PhD
Flavonoids Join the War on Cancer
By Uwe Wenzel, PhD
Oral Chemotherapy for Colorectal Cancer: An Update
By Sunil Sharma, MD
In Vitro Tests to Predict Human Tumor Sensitivity to Cytotoxic Agents
By Axel-R. Hanauske, MD, PhD
An Update on Cancer Chemoprevention
By Tammy Chernin, RPh
Letter From the Editors: A Question of Ownership
By Daniel D. Von Hoff, MD, and J. Lyle Bootman, PhD
Critical Analysis of Recent Phase III Studies for the Treatment of Colorectal Cancer Implications for Future Clinical Trial Design
DISCUSSANTS: John S. Macdonald, MD, Richard Goldberg MD, Leonard B. Saltz, MD, Daniel G. Haller, MD,
and Richard Simon, DSc
Metastasis-Suppressor Genes: A Review and Perspective on an Emerging Field
By Barbara A. Yoshida, Mitchell M. Sokoloff, Danny R. Welch, and Carrie W. Rinker-Schaeffer
Sequential Chemotherapy for the Curative Treatment of Squamous Cell Cancer of the Head and Neck: A New Paradigm
By Marshall R. Posner, MD
Monitoring Chemotherapy in an Aging Population
By Judith A. Smith, Pharm.D, BCOP
Breast Imaging: Economic Issues and Challenges
By Dione M. Farria, MD, MPH, and Stephen A. Feig, MD
A Systematic Approach to Improving Care for Cancer Patients: Focus on Growth Factor Use and Outcomes
By Kimberly A. Bergstrom, PharmD, and Eric T. Herfindal, PharmD, MPH
Are We Prepared for the Genomics Era?
By J. Lyle Bootma
The Genetics of Multiple Myeloma
By Brian Van Ness, PhD
Diagnosis and Treatment of Depression in the Cancer Patient
Tracy L. Skaer, PharmD, Linda M. Robison, MSPH, David A. Sclar, PhD
High-Dose Therapy in Patients with Multiple Myeloma
By Bhawna Sirohi, MBBS, DCH and Ray Powles, MD, MRCP, MRCPath
Pharmacology and Therapeutic Use of Trastuzumab in Breast Cancer
By Imad Treish, PharmD, Rowena Schwartz, PharmD, BCOP, and Celeste Lindley, PharmD, BCPS, FASHP, FCCP
Guest Editor
Research Needs in Myeloma
Gregory R. Mundy, MD
Colorectal Cancer Screening: How Are We Doing and How Can We Improve?
Virender K. Sharma, MD, and Colin W. Howden, MD
Increased Mortality Risk Associated With Medial Breast Tumors May Be Due to Untreated Internal Mammary Node Metastases
Caroline Lohrisch, MD